Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-22
2005-11-22
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S425000, C514S227500, C514S255010, C514S307000, C514S315000, C514S217120, C514S278000, C514S412000, C514S428000, C514S357000, C514S331000, C514S408000, C514S602000, C514S365000, C514S381000, C514S406000, C514S359000, C548S565000, C548S229000, C548S470000, C548S546000, C548S566000, C548S340100, C548S252000, C548S375100, C548S255000, C540S362000, C540S609000, C546S016000, C546S229000, C546S334000, C546S220000
Reexamination Certificate
active
06967196
ABSTRACT:
In accordance with the present invention, there is provided a novel class of sulfonamide compounds. Compounds of the invention contain a core sulfonamide group. Variable moieties connected to the sulfur atom and nitrogen atom of the sulfonamide group include substituted or unsubstituted hydrocarbyl moieties, substituted or unsubstituted heterocycle moieties, polycyclic moieties, halogen, alkoxy, ether, ester, amide, sulfonyl, sulfonamidyl, sulfide, carbamate, and the like. Invention compounds are capable of a wide variety of uses. For example sulfonamide compounds can act to modulate production of amyloid β protein and are useful in the prevention or treatment of a variety of diseases. Pharmaceutical compositions containing invention compounds are also provided. Such compositions have wide utility for the prevention or treatment of a variety of diseases.
REFERENCES:
patent: 5624937 (1997-04-01), Reel et al.
patent: 5981168 (1999-11-01), Reiner et al.
patent: WO 98 02166 (1998-01-01), None
patent: WO 98 22104 (1998-05-01), None
Negishi et al., Journal of Organic Chemistry (1965), 30(1), 43-8.
Linfield et al., Journal of Medicinal Chemistry (1983), 26(12), 1741-6.
FDA mulls drug to slow late-stage Alzheimer's [online], [retrieved on Sep. 24, 2003]. Retrieved from the Internet<URL:http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/index.html>.
*These references are not being furnished because they are US patents or were cited on the international search report.
Bergstrom Carl P.
Chaturvedula Prasad V.
Deshpande Milind S.
Keavy Daniel J.
Lau Wai Yu
Anderson Rebecca
Bristol--Myers Squibb Company
Hoffmann & Baron , LLP
McKane Joseph K.
Merck & Co. , Inc.
LandOfFree
Sulfonamide compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3514392